GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

Strona główna・Stock List・BioArctic AB

B
BioArctic AB

Closed

290 -7.29

Buy Sell

Overview

Share price change

24h

Current

Min

272.2

Max

312.8

Key metrics
By Trading Economics
Income	-979M 97M
Sales	-897M 392M
P/E Sector Avg	25.665 35.733
EPS	1.09
Profit margin	24.623
Employees	119
EBITDA	1.1B 1.1B

Market Stats
By TradingEconomics
Market Cap	6.6B 27B
Previous open	297.29
Previous close	290

BioArctic AB Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 wrz 2025, 20:46 UTC

Earnings

Costco Wholesale Posts Sales Gains in August

4 wrz 2025, 20:42 UTC

Earnings

Broadcom Swings to 3Q Profit, Beats on Sales Outlook

4 wrz 2025, 23:02 UTC

Market Talk

Sky Network TV's Latest Deal Looks Strategically Smart -- Market Talk

4 wrz 2025, 21:46 UTC

Hot Stocks

Lululemon, Broadcom, Docusign: Stocks to Watch Afterhours -- WSJ

4 wrz 2025, 21:23 UTC

Earnings

Broadcom Stock Rises on New AI Chip Customer Order After Earnings Beat -- Barrons.com

4 wrz 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4 wrz 2025, 20:37 UTC

Earnings

Broadcom Posts Earnings Beat. The Stock Is Wavering. -- Barrons.com

4 wrz 2025, 20:32 UTC

Acquisitions, Mergers, Takeovers

Cadence Design Systems: 70% of Consideration to Be Paid in Cash and 30% to Be Paid Through Issuance of Stk to Hexagon >CDNS

4 wrz 2025, 20:31 UTC

Acquisitions, Mergers, Takeovers

GE Aerospace Moves Toward Hybrid Electric Engines. The Stock Is Up. -- Barrons.com

4 wrz 2025, 20:31 UTC

Acquisitions, Mergers, Takeovers

Cadence Design Systems Will Pay About EUR2.7 B for the Business >CDNS

4 wrz 2025, 20:31 UTC

Acquisitions, Mergers, Takeovers

Cadence Design Systems: Acquisition Will Complement System Analysis Portfolio for Automotive, Aerospace, Industrial and Robotics >CDNS

4 wrz 2025, 20:31 UTC

Acquisitions, Mergers, Takeovers

Cadence Design Systems to Acquire Design & Engineering Business of Hexagon AB >CDNS

4 wrz 2025, 20:25 UTC

Earnings

Broadcom Beats Earnings. The Stock Wavers. -- Barrons.com

4 wrz 2025, 20:17 UTC

Earnings

Broadcom 3Q Infrastructure Software Net Revenue $6.79B >AVGO

4 wrz 2025, 20:17 UTC

Earnings

Broadcom 3Q Semiconductor Solutions Net Revenue $9.17B >AVGO

4 wrz 2025, 20:15 UTC

Earnings

Broadcom 3Q EPS 85c >AVGO

4 wrz 2025, 20:15 UTC

Earnings

Broadcom 3Q Cont Ops EPS 85c >AVGO

4 wrz 2025, 20:15 UTC

Earnings

Broadcom 3Q Adj EPS $1.69 >AVGO

4 wrz 2025, 20:15 UTC

Earnings

Broadcom 3Q Net $4.14B >AVGO

4 wrz 2025, 20:15 UTC

Earnings

Broadcom 3Q Rev $15.95B >AVGO

4 wrz 2025, 20:15 UTC

Earnings

Broadcom Sees 4Q Rev $17.4B >AVGO

4 wrz 2025, 19:33 UTC

Acquisitions, Mergers, Takeovers

Private-Equity Firm Pays $2.7 Billion to Buy Back Wealth Firms It Sold Last Year -- Barrons.com

4 wrz 2025, 19:33 UTC

Market Talk

Oil Futures Post Back-to-Back Losses -- Market Talk

4 wrz 2025, 19:14 UTC

Market Talk

U.S. Natural Gas Edges Up As Storage Meets Expectations -- Market Talk

4 wrz 2025, 18:48 UTC

Earnings

These Stocks Are Moving the Most Today: Figma, T. Rowe Price, Credo, Salesforce, American Eagle, HPE, Ciena, and More -- Barrons.com

4 wrz 2025, 17:54 UTC

Acquisitions, Mergers, Takeovers

T. Rowe Stock Jumps After Goldman Agrees to Invest $1 Billion, Partner on Private Funds -- WSJ

4 wrz 2025, 17:54 UTC

Acquisitions, Mergers, Takeovers

Fiserv Didn't Disclose Financial Terms of CardFree Transaction >FI

4 wrz 2025, 17:54 UTC

Acquisitions, Mergers, Takeovers

Fiserv: CardFree an All-In-One Platform Providing Merchants With Customized Order, Pay, and Loyalty Solutions >FI

4 wrz 2025, 17:54 UTC

Acquisitions, Mergers, Takeovers

Fiserv Has Acquired CardFree >FI

4 wrz 2025, 17:15 UTC

Market Talk

Earnings

Global Equities Roundup: Market Talk

Peer Comparison

Price change

BioArctic AB Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.